Clinical Trials in Zhuhai, China
Locations / Zhuhai, China
Delta Trials records 217 clinical trials conducted in Zhuhai, China, making it a notable site of clinical research activity. These trials across 261 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 2 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Zhuhai has changed over time.
217
Total Trials
261
Conditions
2
Terminated since 2020
Browse by condition (261 total)
- Nasopharyngeal carcinoma 11 trialsAll Nasopharyngeal carcinoma trials
- Hepatocellular carcinoma 5 trialsAll Hepatocellular carcinoma trials
- Liver cirrhosis 4 trialsAll Liver cirrhosis trials
- Smoking cessation 4 trialsAll Smoking cessation trials
- Radiotherapy 4 trialsAll Radiotherapy trials
- Non-small cell lung cancer 4 trialsAll Non-small cell lung cancer trials
- Portal hypertension 4 trialsAll Portal hypertension trials
- Asthma 4 trialsAll Asthma trials
- Mobile health 3 trialsAll Mobile health trials
- Liver fibrosis 3 trialsAll Liver fibrosis trials
- Covid-19 pandemic 3 trialsAll Covid-19 pandemic trials
- Surgery 3 trialsAll Surgery trials
- All Recurrent or metastatic nasopharyngeal carcinoma trials
- Nasopharyngeal carcinoma (npc) 3 trialsAll Nasopharyngeal carcinoma (npc) trials
- Metastatic breast cancer 3 trialsAll Metastatic breast cancer trials
- Coronary artery disease 3 trialsAll Coronary artery disease trials
- Coronary heart disease 3 trialsAll Coronary heart disease trials
- Intracranial aneurysm 3 trialsAll Intracranial aneurysm trials
- Physical activity 3 trialsAll Physical activity trials
- Breast cancer 3 trialsAll Breast cancer trials